The most resilient CSCs are known to contribute to drug resistance through adaptation to the selective force of anti‐cancer treatment, regardless of variations in genetic background of cancers.[16] Therefore, we investigated the role of GSTP1 in drug resistance. This evidence concerns the gene GSTP1 and cancer.